M* drives across state lines to seek the healthcare for her preteen daughter that has improved her sense of well-being. She tells very few people where she is going, as few seem to understand. But a nearby state allows a puberty blocker shot that’s recently been banned for minors under 18 in M’s home state. It’s a shot that has been widely given without major concerns for decades to patients with early onset puberty, until the politicking of the trans community dominated airwaves and stigmatized it as “unsafe.” It’s a shot that can help prevent the further need for medication for trans individuals if timed right, which is why the trans-affirming medical community prioritizes its use in younger patients on the verge of puberty. But this process requires a parent and a medical team to trust the intuition and identity of a patient who is still a child.